These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunologic properties of methylcholanthrene-induced sarcomas of neonatally thymectomized mice. Nomoto K; Takeya K J Natl Cancer Inst; 1969 Mar; 42(3):445-53. PubMed ID: 5779635 [No Abstract] [Full Text] [Related]
3. Heterotransplantation of mouse tumors to immunologically paralyzed rats. Suciu-Foca N Cancer Res; 1969 Feb; 29(2):338-48. PubMed ID: 4885388 [No Abstract] [Full Text] [Related]
4. Studies on skin allograft reaction in closed colony black hairy mice previously implanted with selected malignant tumors. Uchiyama M Yokohama Med Bull; 1971 Oct; 22(3):49-71. PubMed ID: 4946489 [No Abstract] [Full Text] [Related]
5. Host response to premalignant mammary tissues. Slemmer G Natl Cancer Inst Monogr; 1972 Dec; 35():57-71. PubMed ID: 4659058 [No Abstract] [Full Text] [Related]
6. [Inhibition of the growth of transplanted tumors in newborn recipients]. Zinzar SN; Svet-Moldavskiĭ GIa; Karmanova NV; Meĭland EN; Osipova TV Vestn Akad Med Nauk SSSR; 1976; (2):21-5. PubMed ID: 178117 [No Abstract] [Full Text] [Related]
7. Concomitant immunity and specific depression of immunity by residual or reinjected syngeneic tumor tissue. Vaage J Cancer Res; 1971 Nov; 31(11):1655-62. PubMed ID: 5121668 [No Abstract] [Full Text] [Related]
8. Studies on the kinetics of transplantation immunity. Phillips ME Cancer Res; 1966 Jan; 26(1):40-7. PubMed ID: 5322597 [No Abstract] [Full Text] [Related]
9. DEMONSTRATION OF SYNGENEIC PREFERENCE IN VITRO. HELLSTROEM KE; HELLSTROEM I; HAUGHTON G Nature; 1964 Nov; 204():661-4. PubMed ID: 14236283 [No Abstract] [Full Text] [Related]
10. Studies on the tumor-host relationship. II. Serum resistant factor(s) produced by tumor transplantation. Tanino T Jpn J Exp Med; 1968 Oct; 38(5):383-92. PubMed ID: 5305973 [No Abstract] [Full Text] [Related]
11. Altered survival times of murine skin allografts from cancer-bearing donors. Kaliss N; Suter RB Transplantation; 1968 Oct; 6(7):844-8. PubMed ID: 4881646 [No Abstract] [Full Text] [Related]
12. Normal tissue antigens of tumor cells. Milas L; Suit HD Tex Rep Biol Med; 1969; 27(2):467-9. PubMed ID: 4900374 [No Abstract] [Full Text] [Related]
13. [Coombs-positive reactions in mice during transplantation of syngeneic tumors]. Buntsevich AM; Mikheeva NV Biull Eksp Biol Med; 1983 May; 95(5):81-4. PubMed ID: 6850095 [TBL] [Abstract][Full Text] [Related]
14. [Autoimmunity of experimental animals with induced carcinoma. 1. Autotransplantability of rats with methylcholanthrene-induced sarcoma]. Takeda K; Aizawa M; Tsuji Y; Yamawaki S; Nakamura K Saishin Igaku; 1965 Oct; 20(10):2826-35. PubMed ID: 5886833 [No Abstract] [Full Text] [Related]
16. Resistance to transplants of recent spontaneous parental line tumors by F1 hybrid hosts. Sanford BH; Soo SF J Natl Cancer Inst; 1971 Jan; 46(1):95-101. PubMed ID: 4993665 [No Abstract] [Full Text] [Related]
17. Antilymphocyte serum and allogeneic inhibition. Fisher B; Soliman O; Fisher ER Cancer Res; 1970 Jan; 30(1):66-8. PubMed ID: 5441081 [No Abstract] [Full Text] [Related]
18. [Experimental significance of anti-sarcoma "PT" antibodies in antineoplastic immunology in the mouse]. Ferrari S; Lucchesi M; Serafini NA Ann Ist Carlo Forlanini; 1966; 26(4):469-79. PubMed ID: 5991599 [No Abstract] [Full Text] [Related]
19. Immunology of spontaneous mammary carcinomas in mice. 3. Immunogenicity of C3H preneoplastic hyperplastic alveolar nodules in C3Hf hosts. Lavrin DH; Blair PB; Weiss DW Cancer Res; 1966 Feb; 26(2):293-304. PubMed ID: 5903180 [No Abstract] [Full Text] [Related]
20. [Increased immunologic reactivity against hepatoma 22A cells in MTV-infected C3H mice in comparison to MTV-free mice]. Lavrovskiĭ VA; Viksler VKh Biull Eksp Biol Med; 1980 Oct; 90(10):467-9. PubMed ID: 6252986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]